Jenny Jingyi Feng MD MSc
Neuroimmunology/Multiple Sclerosis
Neuroimmunologist at Ochsner Health
Join to View Full Profile
Ochsner HealthNew Orleans, LA 70121
Dr. Feng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Neuroimmunology & Multiple Sclerosis, 2018 - 2020- Cleveland Clinic FoundationResidency, Neurology, 2014 - 2018
University of Louisville School of MedicineClass of 2014
Washington University in St. LouisBA, Biology - Neuroscience
Certifications & Licensure
OH State Medical License 2014 - 2027
KY State Medical License 2020 - 2026
LA State Medical License 2021 - 2025
MS State Medical License 2021 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Best Teaching Award Ochsner Health Department of Neurology, 2023
- Best Teaching Award University of Louisville Department of Neurology, 2021
Clinical Trials
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) Start of enrollment: 2021 Dec 16
- Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis Start of enrollment: 2020 Nov 06
- Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls. Start of enrollment: 2022 Jan 25
Publications & Presentations
PubMed
- Clinical characteristics and treatment outcomes in multiple sclerosis patients treated with anti-CD20s who switched to fumarates: a retrospective analysis of a US heal...Aliza B Ben-Zacharia, Jenny J Feng, Brandon P Moss, Nicholas Belviso, Yu Zhang
Journal of Comparative Effectiveness Research. 2025-03-01 - 8 citationsEarly use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.Barry A Singer, Jenny Feng, Horacio Chiong-Rivero
Journal of Neurology. 2024-06-01 - Clinical observation during alemtuzumab administration.Chris Allen, Jenny Feng, Mark Willis, Marisa P. McGinley, Daniel Ontaneda
Multiple Sclerosis and Related Disorders. 2020-01-01
Press Mentions
#MSVirtual2020 – Pediatric MS Patients May Do Best on Intravenous DMTs, Study FindsSeptember 16th, 2020
ACTRIMS Forum: MS Research Updates on the Microbiome, Diet, Brain Networks, and New FrontiersMarch 6th, 2020
MS News That Caught My Eye Last Week: Remyelination Research in Animal Models, Depression and Neurological Function, Ofatumumab Approval Moves CloserMarch 2nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
